Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 24(6): 3344-3351, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32271452

RESUMO

OBJECTIVE: Uterine myomas are the most common benign tumors in females. Most myomas are asymptomatic and require no intervention or further investigations; however, almost a third of women with myomas will require a therapy. Treatment options include pharmacological approaches or surgery, and depend on symptomatology, size, number and desire for future pregnancy. Minimally invasive procedures or alternative medical treatments for handling myomas are preferred, when possible, to the radical abdominal surgery. Vitamin D and epigallocatechin gallate (EGCG) recently proved effective in the management of these benign tumors. Our aim was to verify the effect of combined oral vitamin D and EGCG supplementation in symptomatic women with myomas. PATIENTS AND METHODS: Symptomatic women with myomas were enrolled in this pilot study and divided in two groups: one group treated daily with two tablets of 25 µg vitamin D + 150 mg EGCG + 5 mg vitamin B6, for 4 months; the other group received no treatment (control), for the same period. Volume, number of myomas as well as severity of symptoms (SS) and quality of life (QoL) were analyzed. RESULTS: The total myoma volume significantly decreased by 34.7% in the treated group, whereas it increased by 6.9% in the control group. An improvement in the QoL of women treated with vitamin D, EGCG and vitamin B6 was reported along with a reduction of the SS. CONCLUSIONS: The combined supplementation of vitamin D and EGCG seems to be an optimal approach for the management of myomas and correlated symptoms. For the first time, we showed the cooperative effectiveness as a promising and novel treatment for myomas.


Assuntos
Catequina/análogos & derivados , Leiomioma/tratamento farmacológico , Neoplasias Uterinas/tratamento farmacológico , Vitamina D/administração & dosagem , Administração Oral , Adulto , Catequina/administração & dosagem , Quimioterapia Combinada , Feminino , Humanos , Leiomioma/patologia , Pessoa de Meia-Idade , Projetos Piloto , Qualidade de Vida , Índice de Gravidade de Doença , Resultado do Tratamento , Neoplasias Uterinas/patologia
2.
Int J Gynaecol Obstet ; 28(2): 109-17, 1989 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2563696

RESUMO

In many cases the presence of a myomatous formation in pregnancy begins its effect in a symptomless way and is revealed only by a regular sonographic control or at the time of delivery. In other cases, however, it could represent the cause of several complications, such as increased incidence of abortion extrauterine pregnancy premature breaking of the membranes, premature delivery distocia during delivery or it could itself be the site of necrotic processes. The attitude towards this type of pathology during pregnancy has often varied. The authors report their experiences regarding 408 cases of pregnancies complicated by myoma that were followed with accurate sonographic monitoring and they evaluate the incidence of the principal complications during pregnancy at the time of delivery and the eventual influence on the fetal weight at the time of birth.


Assuntos
Leiomioma/diagnóstico , Complicações Neoplásicas na Gravidez/diagnóstico , Ultrassonografia , Neoplasias Uterinas/diagnóstico , Aborto Espontâneo/etiologia , Adulto , Peso ao Nascer , Parto Obstétrico , Desenvolvimento Embrionário e Fetal , Feminino , Humanos , Recém-Nascido , Leiomioma/complicações , Trabalho de Parto Prematuro/etiologia , Gravidez , Neoplasias Uterinas/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA